Morgan Stanley Surmodics Inc Call Options Transaction History
Morgan Stanley
- $1.27 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SRDX
# of Institutions
125Shares Held
13MCall Options Held
25.5KPut Options Held
3.4K-
Beryl Capital Management LLC Redondo Beach, CA1.54MShares$57.8 Million25.28% of portfolio
-
Black Rock Inc. New York, NY1.17MShares$43.9 Million0.0% of portfolio
-
Trigran Investments, Inc.1.04MShares$39.1 Million4.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA804KShares$30.1 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT782KShares$29.3 Million3.33% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $525M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...